AlphaYouJS
Insider selling
Jeffrey S. Heier sold $25K of Ocular Therapeutix, Inc (OCUL) stock
Jeffrey S. Heier, Chief Scientific Officer of Ocular Therapeutix, Inc (OCUL), sold 3,018 shares of OCUL stock worth $25K, per an SEC Form 4 filed May 28, 2026.
It was an open-market sale.
The trade happened on May 26, 2026, 2 days before it was made public.
OCUL has moved +20.5% since the trade date, from $8.29 to $9.99 (Sep 21, 2026 close).
- Traded
- May 26, 2026
- Disclosed
- May 28, 2026
- Filing delay
- 2 days
- Price since
- +20.5%
- Role
- Chief Scientific Officer
- Source
- SEC Form 4
More OCUL insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.